Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - aureus
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus
aureus
Available for licensing and commercial development are compositions and methods for the treatment and inhibition of Methicillin-resistant Staphylococcus
aureus
(MRSA), a dangerous human pathogen. The invention concerns immunogenic peptides that can be used to induce protective immunity against MRSA, including phenol-soluble modulin (PSM) peptides. In...
Published: 10/28/2024
|
Inventor(s):
Rong Wang
,
Michael Otto
Keywords(s):
Against
,
ANTIBIOTIC
,
AUREUS
,
CA-MRSA
,
DB3XXX
,
DBXXXX
,
DC4XXX
,
DCXXXX
,
DXXXXX
,
fasciitis
,
Gene
,
GenePeptides
,
Immunity
,
Immunogenic
,
Methicillin-resistant
,
MRSA
,
necrotizing
,
necrotizing fasciitis
,
Peptides
,
PMS
,
PSM
,
Staphloccus
,
STAPHYLOCOCCAL
,
Staphylococcus
,
Targets
,
Vaccine
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Vaccines
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease